- World rank, all time
- #26,144 of 42,892
- Rank in Italy
- #738 of 969
- Research works
- 256 ▲ 69% vs 2013–17
- Citations
- 5.3k 20.8 per fractional work
- Top-10% rate
- 10.5% record average 16.5%
- Open access
- 26% world 28%
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.3×. Every wedge is a field page.
- Immunology and Microbiology 8.3×
- Biochemistry, Genetics and Molecular Biology 6.9×
- Pharmacology, Toxicology and Pharmaceutics 2.6×
- Medicine 1.9×
- Neuroscience 1.6×
- Veterinary 1.3×
- Dentistry 1.1×
- Decision Sciences 0.8×
- Agricultural and Biological Sciences 0.7×
- Chemistry 0.6×
- Physics and Astronomy 0.4×
- Economics, Econometrics and Finance 0.3×
- Engineering 0.3×
- Health Professions 0.3×
- Materials Science 0.2×
- Earth and Planetary Sciences 0.2×
- Computer Science 0.1×
- Environmental Science 0.0×
- Social Sciences 0.0×
Who are the top researchers at Italfarmaco (Italy)?
Ranked on the composite score, Christian Steinkühler, P. Bettica and Paolo Mascagni lead among researchers whose main affiliation is Italfarmaco (Italy).
- 1 Christian Steinkühler Italy · #215,678 worldwide 180 citations · 26 works
- 2 P. Bettica Italy · #509,275 worldwide 46 citations · 17 works
- 3 Paolo Mascagni Italy · #761,425 worldwide 57 citations · 26 works
- 4 Gianluca Fossati Italy · #1,353,407 worldwide 17 citations · 30 works
- 5 Alberto Sala Italy · #1,442,101 worldwide 20 citations · 18 works
Which keywords describe research at Italfarmaco (Italy)?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer Therapy, HDAC Inhibitors, Histone Deacetylases, Stem Cells, Muscle Regeneration, Skeletal Muscle Atrophy, BET Bromodomains and PROTACs.
- Natural Killer Cells
- Inflammation
- Fibroblast Activation Protein
- PROTACs
- Skeletal Muscle Atrophy
- Stem Cells
- HDAC Inhibitors
- Cancer Therapy
- Histone Deacetylases
- Muscle Regeneration
- BET Bromodomains
- Tumor Microenvironment
- Immunosuppression
- NK Cell Recognition
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 14 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 14 words, with their numbers
- Cancer Therapy4▲ 33×5 topics
- HDAC Inhibitors3▲ 511×1 topic
- Histone Deacetylases3▲ 511×1 topic
- Stem Cells3▲ 44×2 topics
- Muscle Regeneration2▲ 406×1 topic
- Skeletal Muscle Atrophy2▲ 406×1 topic
- BET Bromodomains2▲ 287×1 topic
- PROTACs2▲ 287×1 topic
- Tumor Microenvironment2▲ 18×4 topics
- Fibroblast Activation Protein2▲ 154×1 topic
- Immunosuppression2▲ 75×1 topic
- Inflammation1▲ 2.4×10 topics
- NK Cell Recognition1▲ 66×1 topic
- Natural Killer Cells1▲ 66×1 topic
Which research topics does Italfarmaco (Italy) publish most on?
By volume in 2022–2025: Histone Deacetylase Inhibitors Research, Muscle Physiology and Disorders, Protein Degradation and Inhibitors and Peptidase Inhibition and Analysis.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Histone Deacetylase Inhibitors Research Molecular Biology 3 works
- 2 Muscle Physiology and Disorders Molecular Biology 2 works
- 3 Protein Degradation and Inhibitors Molecular Biology 2 works
- 4 Peptidase Inhibition and Analysis Oncology 2 works
- 5 Immune Cell Function and Interaction Immunology 1 works
- 6 Immune cells in cancer Immunology 1 works
- 7 Neurogenetic and Muscular Disorders Research Genetics 0 works
- 8 Pelvic floor disorders treatments Rheumatology 0 works
- 9 Cardiomyopathy and Myosin Studies Cardiology and Cardiovascular Medicine 0 works
- 10 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Italfarmaco (Italy)'s research output changed?
Output in 2018–2022 was 69% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Milan
- University of Milan
- Politecnico di Milano
- Università Cattolica del Sacro Cuore
- University of Milano-Bicocca
- Vita-Salute San Raffaele University
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Fondazione IRCCS Istituto Nazionale dei Tumori
- Mario Negri Institute for Pharmacological Research
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.